(R,E)-1-cyclopropyl-4-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-dihydroxy-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)pent-2-en-1-one;(1?,3?,5Z,7E,22E)-24-Cyclopropyl-1,3-dihydroxy-9,10-Secochola-5,7,10(19),22-tetraen-24-one (90%);MC 1046; Calcipotriol, anhydrous specified impurity A [EP];9,10-Secochola-5,7,10(19),22-tetraen-24-one, 24-cyclopropyl-1,3-dihydroxy-, (1alpha,3beta,5Z,7E,22E)-;(4R,E)-1-Cyclopropyl-4-((1R,7AR,E)-4-((Z)-2-((3S,5R)-3,5-dihydroxy-2-methylenecyclohexylidene)ethylidene)-7A-methyloctahydro-1H-inden-1-yl)pent-2-en-1-one;
Calcipotriol EP Impurity A is a fully characterized chemical compound used as a reference standard of API Calcipotriol. The standard offered is compliant with regulatory guidelines. Calcipotriol EP Impurity A is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 126860-83-1
